Role of microemuslsions in advanced drug delivery
Source abstract
Abstract
Microemulsions have gained significant attention from formulation scientists since the time they have been discovered, because of their excellent properties related to their stability, solubility, simplicity, and formulation aspects. The application of microemulsions is not limited to drug delivery via the oral, topical or ocular routes, but may also be seen in cosmetics, immunology, sensor devices, coating, textiles, analytical chemistry, and spermicide. Finally, the objective of this review is to discuss briefly the applications of microemulsions in advanced drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Surfactants and Colloidal Systems · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (71)
Show source-provided references
1. Akay S · Transplant Proc · 2005 · 37 · 218810.1016/j.transproceed.2005.03.024 ↗
2. Burrows HD · Adv Colloid Interface Scie · 2001 · 89 · 48510.1016/S0001-8686(00)00075-0 ↗
3. 10.1016/j.aca.2007.10.04910.1016/j.aca.2007.10.049 ↗
4. 10.4103/0973-8398.4917210.4103/0973-8398.49172 ↗
5. 10.1002/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO;2-R10.1002/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO;2-R ↗
6. 10.3109/1061186X.2014.95066410.3109/1061186X.2014.950664 ↗
7. 10.1111/j.1468-2494.2012.00737.x10.1111/j.1468-2494.2012.00737.x ↗
8. 10.1021/la00021a01610.1021/la00021a016 ↗
9. 10.1007/s11095-010-0130-x10.1007/s11095-010-0130-x ↗
10. 10.1016/j.ejps.2013.11.01610.1016/j.ejps.2013.11.016 ↗
11. 10.3109/21691401.2014.91671510.3109/21691401.2014.916715 ↗
12. 10.2174/2210304x1120204000510.2174/2210304x11202040005 ↗
13. 10.1517/17425247.2014.89101410.1517/17425247.2014.891014 ↗
14. 10.2174/2210303111303666001510.2174/22103031113036660015 ↗
15. 10.2174/221030310399913121111041410.2174/2210303103999131211110414 ↗
16. 10.2174/2210304x1120204000310.2174/2210304x11202040003 ↗
17. 10.1615/CritRevTherDrugCarrierSyst.201401110410.1615/CritRevTherDrugCarrierSyst.2014011104 ↗
18. 10.1615/CritRevTherDrugCarrierSyst.201401012210.1615/CritRevTherDrugCarrierSyst.2014010122 ↗
19. Garg T · J Drug Target · 2014 · 1
20. Garg T · Drug Deliv · 2014
21. Garg T · Int J Pharm Sci Rev Res · 2011 · 7 · 211
22. Garg T · J Pharm Res · 2011 · 4 · 2097
23. 10.1615/CritRevTherDrugCarrierSyst.v29.i110.1615/CritRevTherDrugCarrierSyst.v29.i1 ↗
24. 10.1615/CritRevTherDrugCarrierSyst.201300725910.1615/CritRevTherDrugCarrierSyst.2013007259 ↗
25. Gibaud S · Expert Opin Drug Deliv · 2012 · 9 · 93710.1517/17425247.2012.694865 ↗
26. 10.1016/0021-9797(70)90070-610.1016/0021-9797(70)90070-6 ↗
27. Goyal AK · DNA RNA Nanobiotechnol Med Diagnos Treatment Dis · 2013 · 6710.1007/978-3-662-45775-7_4 ↗
28. Goyal G · Drug Deliv · 2013
29. 10.1615/CritRevTherDrugCarrierSyst.201400811710.1615/CritRevTherDrugCarrierSyst.2014008117 ↗
30. 10.1615/CritRevTherDrugCarrierSyst.201401012310.1615/CritRevTherDrugCarrierSyst.2014010123 ↗
31. 10.1166/jbt.2014.121410.1166/jbt.2014.1214 ↗
32. Jahanzad F · Macromol Symp. · 2007 · 14510.1002/masy.200751317 ↗
33. Johal HS · Drug Deliv · 2014 · 1
34. Joshi D · Drug Deliv · 2014 · 1
35. Joshi D · Curr Drug Deliv · 2014
36. Kalia V · Artif Cells Nanomed Biotechnol · 2014 · 1
37. 10.2174/2210303111303666001810.2174/22103031113036660018 ↗
38. Kaur M · Artif Cells Nanomed Biotechnol · 2014 · 1
39. 10.1615/CritRevTherDrugCarrierSyst.201400828510.1615/CritRevTherDrugCarrierSyst.2014008285 ↗
40. Kaur M · Drug Deliv · 2014
41. Kaur N · Drug Deliv · 2014 · 1
42. Kaur P · Drug Deliv · 2014 · 1
43. Kaur P · Drug Deliv · 2014 · 1
44. Kaur P · J Drug Target · 2014 · 1
45. Kaur R · Artif Cells Nanomed Biotechnol · 2014 · 1
46. Kaur R · Drug Deliv · 2014 · 1
47. 10.1615/CritRevTherDrugCarrierSyst.201401052710.1615/CritRevTherDrugCarrierSyst.2014010527 ↗
48. Kaur V · J Drug Target · 2014 · 1
49. Malik R · J Drug Target · 2014 · 1
50. Marwah H · Drug Deliv · 2014 · 1
51. Modgill V · Artif Cells Nanomed Biotechnol · 2014 · 1
52. Modgill V · Curr Drug Deliv · 2014
53. Morie A · Artif Cells Nanomed Biotechnol · 2014 · 1
54. 10.1016/j.ijpharm.2007.08.05710.1016/j.ijpharm.2007.08.057 ↗
55. Pabreja S · Artif Cells Nanomed Biotechnol · 2014 · 1
56. Rohilla R · Drug Deliv · 2014 · 1
57. Rohilla R · Drug Deliv · 2014 · 1
58. Schott H · 1985 · 74 · 794
59. 10.1021/j150580a02710.1021/j150580a027 ↗
60. Shalviri A · J Pharm Pharm Sci · 2011 · 14 · 31510.18433/J38P4V ↗
61. Sharma A · Artif Cells Nanomed Biotechnol · 2014 · 1
62. Sharma R · Artif Cells Nanomed Biotechnol · 2014 · 1
63. 10.1615/CritRevTherDrugCarrierSyst.201400819310.1615/CritRevTherDrugCarrierSyst.2014008193 ↗
64. Shi FF · Nanotechnology · 2007 · 18 · 26530110.1088/0957-4484/18/26/265301 ↗
65. 10.1021/j150665a06510.1021/j150665a065 ↗
66. Singh B · Artif Cells Nanomed Biotechnol · 2014 · 1
67. Singh H · Artif Cells Nanomed Biotechnol · 2014
68. Singh K · Am J Pharm Tech Res · 2012 · 2 · 113
69. Singh K · Int J Institut Pharm Life sci · 2012 · 2 · 58
70. Singh O · J Pharm · 2014 · 1
71. 10.1002/jsfa.568610.1002/jsfa.5686 ↗